The Alliance for Cancer Gene Therapy (ACGT) supports the extraordinary potential offered by cell and gene-based therapies to accelerate effective and safe treatment of all types of cancer. Founded in 2001 by Greenwich residents Barbara and Edward Netter, it is the only national non-profit organization committed exclusively to cancer gene therapy research and is identified by the BBB as an Accredited Charity One hundred percent (100%) of all funds raised by ACGT goes directly to support medical research.

Since its inception in 2001, ACGT has issued over $20 million in research grants to 33 ACGT Research Fellows representing such leading research institutions as Harvard Medical School, Johns Hopkins University School of Medicine, Mayo Clinic, St. Jude's Children's Hospital, Duke University, The Salk Institute, University of Pennsylvania, Memorial Sloan-Kettering, University of Pittsburgh's School of Medicine, and the University of Chicago. Identified through a rigorous selection procedure, the scientists and their research projects address brain, breast, lymphoma/leukemia, prostate, breast, lung, and ovarian cancer among others.